We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

204 hedge funds and large institutions have $3.37B invested in Immunomedics Inc in 2019 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 73 increasing their positions, 55 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more call options, than puts

Call options by funds: $68.1M | Put options by funds: $17.7M

46% more capital invested

Capital invested by funds: $2.3B → $3.37B (+$1.07B)

38% more funds holding in top 10

Funds holding in top 10: 8 → 11 (+3)

33% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 55

0% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 49

0% less funds holding

Funds holding: 205 → 204 (-1)

Holders
204
Holders Change
-1
Holders Change %
-0.49%
% of All Funds
4.41%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.24%
New
49
Increased
73
Reduced
55
Closed
49
Calls
$68.1M
Puts
$17.7M
Net Calls
+$50.4M
Net Calls Change
+$89M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$236M
2
BC
Boxer Capital
California
+$47.5M
3
TCM
TimesSquare Capital Management
New York
+$37.2M
4
Fiera Capital (Canada)
Fiera Capital (Canada)
Quebec, Canada
+$33.4M
5
DM
Deerfield Management
New York
+$31.6M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$59.7M
2
RCM
RA Capital Management
Massachusetts
-$43.1M
3
Millennium Management
Millennium Management
New York
-$38.9M
4
WRF
Waddell & Reed Financial
Kansas
-$33.3M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$24.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
WG
226
Winton Group
United Kingdom
– -$312K -21,852 Closed
TI
227
Trexquant Investment
Connecticut
– -$279K -19,545 Closed
MWNA
228
Marshall Wace North America
New York
– -$265K -18,555 Closed
CL
229
CSS LLC
Illinois
– -$260K -18,194 Closed
Mackenzie Financial
230
Mackenzie Financial
Ontario, Canada
– -$228K -16,010 Closed
VEA
231
Virtus ETF Advisers
New York
– -$226K -15,848 Closed
EWA
232
Exencial Wealth Advisors
Oklahoma
– -$217K -15,172 Closed
BFS
233
Bradley Foster & Sargent
Connecticut
– -$200K -14,000 Closed
BAAM
234
Baker Avenue Asset Management
California
– -$182K -12,751 Closed
HF
235
HRT Financial
New York
– -$166K -11,676 Closed
Balyasny Asset Management
236
Balyasny Asset Management
Illinois
– -$164K -11,520 Closed
QSS
237
Quantitative Systematic Strategies
Florida
– -$157K -11,031 Closed
CL
238
Choreo LLC
Illinois
– -$153K -10,699 Closed
TAM
239
Tiverton Asset Management
Delaware
– -$140K -9,795 Closed
PRC
240
Pearl River Capital
Michigan
– -$66K -4,658 Closed
NSIM
241
North Star Investment Management
Illinois
– -$50K -3,500 Closed
GHCM
242
Glen Harbor Capital Management
California
– -$38K -2,652 Closed
KCM
243
Karp Capital Management
California
– -$33K -2,300 Closed
MCIM
244
Meadow Creek Investment Management
Georgia
– -$31K -2,184 Closed
CA
245
Claro Advisors
Massachusetts
– -$41K -1,979 Closed
EP
246
Elkfork Partners
Oregon
– -$24K -1,716 Closed
IA
247
IFP Advisors
Florida
– -$23K -1,507 Closed
AIL
248
AGF Investments LLC
Ontario, Canada
– -$19K -1,365 Closed
TAM
249
Tyers Asset Management
Texas
– -$18K -1,248 Closed
TRCT
250
Tower Research Capital (TRC)
New York
– -$7K -487 Closed
7 8 9
10
11

IMMU Hedge Fund Activity: Q1 2019 in Review

204 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q1 2019, worth a combined $3.37B — up 46% from $2.3B a quarter earlier.

Fund positioning in IMMU was balanced in Q1 2019: 49 funds opened new positions, 49 closed out, 73 added to existing stakes and 55 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $236M. The largest seller was T. Rowe Price Associates, cutting an estimated $59.7M.

  • 204 institutional investors held Immunomedics Inc (IMMU) as of Q1 2019, down from 205 in Q4 2018.
  • Funds reported $3.37B of Immunomedics Inc stock for Q1 2019, up 46% quarter-over-quarter.
  • 49 funds opened new Immunomedics Inc positions in Q1 2019 and 49 closed out, a net change of 0 holders.
  • The largest Immunomedics Inc buyer in Q1 2019 was Fidelity Investments, an estimated $236M added.
  • The largest Immunomedics Inc seller in Q1 2019 was T. Rowe Price Associates, an estimated $59.7M sold.

Based on aggregated 13F filings for Q1 2019.